Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06366347
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-04-08
Brief Title:
ALPINE Maintenance LetrozoleAbemaciclib vs Pembrolizumab
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute